21 results match your criteria: "Hospital de Santa Cruz-CHLO[Affiliation]"
Pol J Pathol
March 2022
Pathology, Hospital de Santa Cruz - CHLO, Lisboa, Portugal.
The question of the utility of Endomyocardial Biopsy (EMB) often and recurrently raises. It is claimed that the image techniques provide identical results without the risks of an invasive procedure. It is a fact that the impressive technico-scientific development of cardiovascular imagological methodologies covers a broad spectrum of diagnosis.
View Article and Find Full Text PDFRev Port Cardiol (Engl Ed)
November 2020
Department of Cardiology, Hospital de Santa Cruz - CHLO, Carnaxide, Portugal. Electronic address:
Catheter Cardiovasc Interv
November 2020
Interventional Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, Padua, Italy.
Objectives: Aim of this study is to evaluate safety, feasibility, and mid-term outcome of transcatheter aortic valve implantation (TAVI) in cardiogenic shock (CS).
Background: Balloon aortic valvuloplasty in patients with severe aortic valve stenosis (SAS) complicated by CS is indicated but associated with a grim prognosis. TAVI might be a more reasonable treatment option in this setting but data are scant.
Virchows Arch
June 2020
Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.
The adult congenital heart diseases (ACHD) population is exceeding the pediatric congenital heart diseases (CHD) population and is progressively expanding each year, representing more than 90% of patients with CHD. Of these, about 75% have undergone surgical and/or percutaneous intervention for palliation or correction. Autopsy can be a very challenging procedure in ACHD patients.
View Article and Find Full Text PDFJACC Cardiovasc Interv
October 2018
Hôpital Privé d'Antony, Antony, France.
Rev Port Cardiol (Engl Ed)
October 2018
Hospital de Santa Cruz-CHLO, Carnaxide, Portugal. Electronic address:
Background: We aimed to evaluate the impact of thrombus aspiration (TA) during primary percutaneous coronary intervention (P-PCI) in 'real-world' settings.
Methods: We performed a retrospective study, using data from the National Registry of Interventional Cardiology (RNCI 2006-2012, Portugal) with ST-elevation myocardial infarction (STEMI) patients treated with P-PCI. The primary outcome, in-hospital mortality, was analysed through adjusted odds ratio (aOR) and 95% confidence intervals (95%CI).
Appl Physiol Nutr Metab
March 2018
f College of Applied Health Sciences - University of Illinois at Chicago, Chicago, IL 60612, USA.
Increasing energy expenditure (EE) in cardiac patients remains a challenge. Exercise approaches in cardiac rehabilitation/secondary prevention programs (CR/SP) have consistently resulted in minimal weight loss, due in part to the low exercise-related EE. The purpose of this study was to measure the EE among patients participating in a routine exercise session of Phase III maintenance CR/SP, where a recreational activity was introduced.
View Article and Find Full Text PDFVirchows Arch
December 2017
University Hospital of Lausanne, University Center of Legal Medicine, Lausanne and Geneva, Chemin de la Vulliette 4, 25, 1000, Lausanne, Switzerland.
Although sudden cardiac death (SCD) is one of the most important modes of death in Western countries, pathologists and public health physicians have not given this problem the attention it deserves. New methods of preventing potentially fatal arrhythmias have been developed and the accurate diagnosis of the causes of SCD is now of particular importance. Pathologists are responsible for determining the precise cause and mechanism of sudden death but there is still considerable variation in the way in which they approach this increasingly complex task.
View Article and Find Full Text PDFCirc Cardiovasc Interv
June 2017
From the Department of Cardiology, University Hospital, Lille, France (E.V.B., F.V.); INSERM U1011, Lille-II-University, France (E.V.B., F.V.); Hospital Fernando da Fonseca, Amadora, Portugal (S.-B.B.); Hospital de Santa Cruz - CHLO, Carnaxide, Portugal (L.R.); Statistical Department, St. Jude Medical Inc, St Paul, MN (J.H.); Hôpital Louis Pradel, Lyon, France (G.R.); INSERM 1060 CARMEN, Claude Bernard University Lyon, France (G.R.); Centro Hospitalar Vila Nova de Gaia, Portugal (L.S.); Clinique Sainte Clotilde, Saint Denis de la Réunion, France (C.P.); Hospital Santa Marta - Centro Hospitalar Lisboa Central, Lisboa, Portugal (R.R.); CHU La Timone, Marseille, France (T.C.); Hospital Garcia de Orta, Almada, Portugal (R.C.); CHU Mondor, Créteil, France (E.T.); Centro Hospitalar Universitário Coimbra, Portugal (E.J.); CH d'Annecy, France (L.B.); Hospital Divino Espirito Santo, Ponta Delgada, Portugal (C.M.); C.H.I.T.S. Hôpital Sainte Musse, Toulon, France (D.B.); Hospital Geral dos Covões - Centro Hospitalar Coimbra, Portugal (M.C.); Centre Hospitalier Haguenau, France (M.H.); Hospital Santa Maria - Centro Hospitalar Lisboa Norte, Portugal (E.O.); Hôpital de la Croix-Rousse, Lyon, France (C.B.); Hospital de Braga, Portugal (J.C.); Institut Pasteur de Lille-INSERM, France (J.D.); Hospital São Teotónio, Viseu, Portugal (J.P.); Hôpital Lariboisière, Paris, France (G.S.); Centro Hospitalar Setúbal, Portugal (N.F.); Centre Hospitalier Valence, France (C.B.); Hospital Santo André - Centro Hospitalar Leiria-Pombal, Portugal (J.G.); Hôpital Albert Schweizer, Colmar, France (N.L.); Hospital Dr. Nélio Mendonça, Funchal, Portugal (B.S.); Centre Hospitalier La Durance, Avignon, France (P.B.); Hospital Geral Santo António - Centro Hospitalar do Porto, Portugal (M.-J.S.); Centre Hospitalier Amiens Sud, Amiens, France (L.L.); Centro Hospitalar São João, Porto, Portugal (J.C.S.); Centro Hospitalar Tâmega e Sousa, Penafiel, Portugal (A.R.); Centro Hospitalar Trás-os-Montes e Alto Douro - Unidade Hospitalar Vila Real, Portugal (L.S.); Hospital Espírito Santo, Évora, Portugal (R.F.); and Hopital Privé d'Antony, France (P.D.).
Background: Fractional flow reserve (FFR) is not firmly established as a guide to treatment in patients with acute coronary syndromes (ACS). Primary goals were to evaluate the impact of integrating FFR on management decisions and on clinical outcome of patients with ACS undergoing coronary angiography, as compared with patients with stable coronary artery disease.
Methods And Results: R3F (French FFR Registry) and POST-IT (Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease), sharing a common design, were pooled as PRIME-FFR (Insights From the POST-IT and R3F Integrated Multicenter Registries - Implementation of FFR in Routine Practice).
Rev Port Cardiol
March 2017
Serviço de Cardiologia, Hospital de Santa Cruz - CHLO, Carnaxide, Portugal. Electronic address:
Rev Port Cardiol
February 2015
Serviço de Cardiologia, Hospital de Santo Antonio, CHP, Portugal; Unidade Curricular de Medicina I, Instituto de Ciências Biomédicas Abel Salazar, UP, Porto, Portugal.
There is a marked contrast between the high prevalence of hypertension and the low rates of adequate control. A subset of patients with suboptimal blood pressure control have drug-resistant hypertension, in the pathophysiology of which chronic sympathetic hyperactivation is significantly involved. Sympathetic renal denervation has recently emerged as a device-based treatment for resistant hypertension.
View Article and Find Full Text PDFRev Port Cardiol
October 2014
Unidade de Intervenção Cardiovascular (UNICARV), Serviço de Cardiologia, Hospital de Santa Cruz - CHLO, Lisboa, Portugal.
Introduction: Until the development of drug-eluting stents (DES), diffuse in-stent restenosis (ISR) was the main limitation of bare-metal stents in percutaneous coronary intervention (PCI). Among the different treatments available, intracoronary brachytherapy (BT) emerged as one of the most promising, although it was almost abandoned with the increasing use of DES.
Objective: To assess the Portuguese experience with 90Sr/90Y beta brachytherapy for the treatment of diffuse ISR regarding long-term (>10 years) major adverse cardiac events (MACE) and angiographic restenosis.
Rev Port Cardiol
December 2013
Unidade de Intervenção Cardiovascular (UNICARV), Serviço de Cardiologia, Hospital de Santa Cruz-CHLO, Carnaxide, Portugal.
Background: Bioresorbable vascular scaffolds (BVS) were recently approved for percutaneous coronary intervention in Europe. The aim of this position statement is to review the information and studies on available BVS, to stimulate discussion on their use and to propose guidelines for this treatment option in Portugal.
Methods And Results: A working group was set up to reach a consensus based on current evidence, discussion of clinical case models and individual experience.
Rev Port Cardiol
January 2012
Serviço de Cardiologia, Hospital de Santa Cruz - CHLO, Carnaxide, Portugal.
A 2-day-old male infant required a conventional VVI pacemaker for congenital atrioventricular block. Three years later, he developed progressive heart failure due to left ventricular (LV) dysfunction and mitral regurgitation despite optimized medical treatment, and a cardiac resynchronization therapy (CRT) device was implanted. This is the first Portuguese report of CRT in a pediatric patient.
View Article and Find Full Text PDFRev Port Cardiol
November 2011
Serviço de Cardiologia, Hospital de Santa Cruz -CHLO, Carnaxide, Portugal.
We describe the case of a 76-year-old man with a history of ischemic heart disease and functional mitral regurgitation who over the previous six months had experienced worsening of functional class (NYHA III/IV) under optimal medical therapy, without ischemic symptoms and with negative ischemic tests. Mitral valve annuloplasty was considered. As the patient presented left bundle branch block on the surface ECG, cardiac resynchronization therapy (CRT) was also considered.
View Article and Find Full Text PDFRev Port Cardiol
October 2010
Serviço de Cardiologia, Hospital de Santa Cruz-CHLO, Lisboa, Portugal.
The authors report the case of an 82-year-old female patient with non-ischemic dilated cardiomyopathy who developed worsening heart failure functional class despite optimal medical therapy. As the patient met criteria for cardiac resynchronization, a CRT-P device was implanted, but due to technical difficulties, the left ventricular lead was implanted in the anterior coronary vein. In the absence of any benefit from the procedure, a new left ventricular lead was implanted in posterolateral position with good clinical and echocardiographic response.
View Article and Find Full Text PDFRev Port Cardiol
February 2010
Hospital de Santa Cruz -CHLO, Carnaxide, Portugal.
Background: A telemedicine program was initiated in November 2000 between the Pediatric Cardiology Department of a tertiary care hospital in Lisbon and pediatricians and obstetricians from three remote Portuguese hospitals: two in mainland Portugal and one in the Azores. Images were transmitted by a telemedicine link over three integrated service digital network (ISDN) lines to a regional pediatric cardiology unit for interpretation by a consultant pediatric cardiologist.
Methods: We performed a retrospective review of all teleconsultations at our Department between November 2000 and December 2007.
Rev Port Cardiol
November 2009
Departamento de Ecocardiografia, Serviço de Cardiologia, Hospital de Santa Cruz CHLO, Carnaxide, Portugal.
Introduction: Ischemic mitral regurgitation (IMR) after myocardial infarction (MI) results from changes in left ventricular geometry, which may involve the entire ventricular cavity (global remodeling) or predominantly affect the infarct zone (regional remodeling). The relative importance of these two distinct but not mutually exclusive mechanisms in generating IMR has been a matter of debate. The aim of our study was to assess the relative contribution of global versus inferior and inferior-lateral left ventricular dyssynergy in the development of significant IMR after MI.
View Article and Find Full Text PDFRev Port Cardiol
March 2009
Hospital de Santa Cruz - CHLO, Carnaxide, Portugal.
Introduction: Renal insufficiency is associated with increased mortality and morbidity from cardiac surgery. Serum creatinine (SCr) values are routinely used for the assessment of renal dysfunction. However, this parameter can overestimate renal function, especially in low-weight and elderly patients, who can have normal creatinine values despite impaired renal function.
View Article and Find Full Text PDFTransplant Proc
April 2009
Department of Pathology, Hospital de Santa Cruz-CHLO, Lisbon, Portugal.
Objective: Acute antibody-mediated (humoral) rejection is a major cause of morbidity, graft loss, and mortality among heart transplant patients. Herein we have presented our experience using C4d to characterize humoral rejection.
Materials And Methods: All nonformalin-fixed cardiac graft biopsies (protocol or emergency) received between May 2007 and May 2008 were examined by immunofluorescence for C4d.